SIGA Technologies Secures Five-Year Supply Agreement for TPOXX in Canada
What happened
SIGA Technologies secured a five-year supply agreement for its smallpox treatment TPOXX with Canada’s Department of National Defence. The contract includes $9 million in firm commitments over the first three years, with up to $6 million available in options. The company also stated that it expects a new U.S. government procurement contract, although the timing remains uncertain.
From dailypolitical.com
Why it matters
The Canadian agreement provides SIGA Technologies with significant future revenue streams. This follows a period where the company reported no product sales in the third quarter of 2026, after its final delivery under an existing U.S. government contract in the second quarter.
From dailypolitical.com
Who's involved
- SIGA TechnologiesAmerican pharmaceutical company that signed the supply agreement
- Diem NguyenChief Executive Officer of SIGA Technologies
- NasdaqStock exchange where SIGA Technologies is listed
- FDARegulatory body for SIGA Technologies product approval
- Department of Health & Human ServicesGovernment department that receives products from SIGA Technologies
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- SIGA TechnologiesSpeculative
SIGA Technologies might see increased revenue from the five-year Canadian contract and potential U.S. procurement
Keep exploring
The entities involved
-
SIGA Technologies
American pharmaceutical
Nothing else this week.
-
Diem Nguyen
researcher
Nothing else this week.